⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 26, 2024Journal of Antimicrobial Chemotherapy

Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial)

Emuri Abé Roland Landman Lambert Assoumou Karine Amat Sidonie Lambert-Niclot Jonathan Bellet Séverine Gibowski Pierre‐Marie Girard Laurence Morand‐Joubert Pierre de Truchis Jean‐Claude Alvarez

View Full Paper

Ask AI

Bookmark

Share

Abstract

Charaterization of the plasma concentrations of antiretrovirals in a 4-days-a-week maintenance treatment strategy in the ANRS-170-QUATUOR study.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Abé et al. (2024) studied this question.

synapsesocial.com/papers/68e7253fb6db64358769ea5c https://doi.org/10.1093/jac/dkae112

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cost-effectiveness of a 4 days-a-week triple therapy in persons living with HIV: an ancillary study of the ANRS 170 QUATUOR noninferiority trial2024 · 1 citations
2Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patientsCohort Study · 2021 · 2 citations
3Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in SpainHuman Clinical Trial · 2026
4Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral SuppressionPilot Study · 2005 · 149 citations
5Antiviral activity, safety and PK/PD of ACC017 in antiretroviral naïve HIV‐infected adults: A randomized, double‐blind, placebo/dose‐parallel‐controlled short‐term monotherapy study2025